Plain-English translation of NCT06105931 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Researchers at Yale University want to understand why some young people with type 1 diabetes develop heart disease risk factors, even when they have a healthy weight. This study will measure how fat is distributed in your body, how your liver handles insulin, and how your body responds to fatty foods over one year. The information gathered will help inform future research on treating obesity in people with type 1 diabetes.
Young adults with type 1 diabetes can develop signs of heart disease risk even when they maintain a normal weight. Doctors need better ways to identify which patients are at highest risk so they can help them earlier. This study will create reference data to understand these hidden risk factors.
Over one year, you will visit Yale University several times for specialized tests. These include an abdominal MRI scan to measure fat distribution, a special test called a clamp study (which measures how your body uses insulin), a DEXA scan (a painless bone and body composition scan), and a meal test where you eat a fatty meal and have your blood checked afterward. The entire study involves medical tests only — no medications to take at home.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States